# This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.

> **NCT06616025** · PHASE3 · RECRUITING · sponsor: **Neuraptive Therapeutics Inc.** · enrollment: 98 (estimated)

## Conditions studied

- Peripheral Nerve Injury Upper Limb
- Peripheral Nerve Injury (PNI)

## Interventions

- **COMBINATION_PRODUCT:** NTX-001 (PEG-Fusion)

## Key facts

- **NCT ID:** NCT06616025
- **Lead sponsor:** Neuraptive Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-10
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-04-30
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06616025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06616025, "This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06616025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*